Table 1 Patient clinical information and quality assessment.
Sample ID | ID type | Age at diagnosis | Gender | Living status | Sample type | Cellularity (%) |
|---|---|---|---|---|---|---|
OS-01 | LM1 | Unknown | Male | Deceased | lung metastasis | 50 |
| Â | LM2 | Â | Â | Â | lung metastasis | 50 |
OS-02 | LM | 5 | Male | Alive | lung metastasis | 90 |
OS-04 | LM | 16 | Male | Deceased | lung metastasis | 60 |
OS-05 | LM | 16 | Male | Deceased | lung metastasis | 60 |
OS-06 | R(M) | 17 | Male | Deceased | primary | 60 |
| Â | LM | Â | Â | Â | lung metastasis | 90 |
OS-07 | B(M) | 14 | Male | Deceased | primary biopsy | 20 |
| Â | R(M) | Â | Â | Â | primary | 80 |
| Â | LM | Â | Â | Â | lung metastasis | 80 |
OS-08 | R(L) | 13 | Female | Alive | primary | 70 |
OS-09 | B(L) | 15 | Female | Alive | primary biopsy | 60 |
OS-10 | R(L) | 15 | Female | Alive | primary | 40 |
OS-11 | B(L) | 38 | Female | Alive | primary biopsy | 60 |
OS-12 | B(L) | 13 | Male | Alive | primary biopsy | 50 |
OS-13 | R(M) | 76 | Female | Deceased | primary | 90 |
OS-14 | R(M) | 84 | Female | Deceased | primary | 80 |
OS-15 | R(L) | 63 | Male | Alive | primary | 50 |
OS-16 | R(M) | 29 | Female | Alive | biopsy | 80 |
OS-17 | R(L) | 60 | Female | Deceased | primary | 80 |
| Â | C1(L) | Â | Â | Â | recurrence | 80 |
| Â | C2(L) | Â | Â | Â | recurrence | 80 |
OS-18 | B(M) | 23 | Female | Alive | biopsy | 60 |
OS-19 | R(M) | 53 | Male | Alive | primary | 70 |
OS-20 | R(L) | 83 | Female | Alive | primary | 80 |
OS-21 | R(L) | 17 | Male | Alive | primary | 80 |
OS-22 | LM | 68 | Male | Deceased | lung metastasis | 80 |
OS-23 | C(M) | 42 | Female | Deceased | recurrence | 80 |
| Â | LM | Â | Â | Â | lung metastasis | 80 |
OS-24 | R(L) | 85 | Female | Deceased | primary | 80 |
OS-25 | R(L) | 31 | Male | Alive | primary | 90 |
OS-26 | R(L) | 15 | Male | Alive | biopsy | 90 |
OS-27 | R(M) | 74 | Male | Deceased | primary | 90 |
OS-28 | R(M) | 13 | Male | Deceased | biopsy | 90 |
OS-29 | B(M) | 58 | Male | Deceased | biopsy | 90 |
| Â | C1(M) | Â | Â | Â | biopsy of recurrence | 90 |
| Â | C2(M) | Â | Â | Â | recurrence | 70 |
| Â | LM | Â | Â | Â | lung metastasis | 100 |
